Stock Rating Downgrade In the last week the Value Trend Rating for Scully Royalty Ltd (NYSE: SRL) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Scully Royalty Ltd […]
Stock Rating Downgrade In recent days the Value Trend Rating for PHX Minerals Inc (NYSE: PHX) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action On 1/12/24, PHX Minerals […]
Stock Rating Upgrade The Value Trend Rating for Novo Nordisk A/S (NYSE: NVO) improved of late from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in […]
Stock Rating Upgrade In recent days the Value Trend Rating for Trinseo PLC (NYSE: TSE) improved from D to C reflecting improving fundamentals and high Appreciation Potential. Recent Price Action On 1/12/24, Trinseo PLC (NYSE: […]
Stock Rating Downgrade The Value Trend Rating for Fate Therapeutics Inc (NASDAQ: FATE) weakened recently from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our […]
Stock Rating Upgrade The Value Trend Rating for Lazard Ltd (NYSE: LAZ) improved in recent days from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Camtek Ltd (NASDAQ: CAMT) weakened during the last several trading days. CAMT’s current Value Trend Rating is C and the […]
Stock Rating Upgrade The Value Trend Rating for AKAMAI TECHNOLOGIES INC (NASDAQ: AKAM) improved recently from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our […]
Stock Rating Upgrade The Value Trend Rating for IDT Corp (NYSE: IDT) improved in recent days from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in […]
Stock Rating Downgrade In recent days the Value Trend Rating for Astrazeneca PLC (NASDAQ: AZN) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Astrazeneca PLC (NASDAQ: AZN) stock […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research